1. Home
  2. TYRA vs TEN Comparison

TYRA vs TEN Comparison

Compare TYRA & TEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • TEN
  • Stock Information
  • Founded
  • TYRA 2018
  • TEN 1993
  • Country
  • TYRA United States
  • TEN Greece
  • Employees
  • TYRA N/A
  • TEN 3000
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • TEN
  • Sector
  • TYRA Health Care
  • TEN
  • Exchange
  • TYRA Nasdaq
  • TEN NYSE
  • Market Cap
  • TYRA 422.6M
  • TEN 480.8M
  • IPO Year
  • TYRA 2021
  • TEN N/A
  • Fundamental
  • Price
  • TYRA $8.92
  • TEN $16.22
  • Analyst Decision
  • TYRA Strong Buy
  • TEN Buy
  • Analyst Count
  • TYRA 6
  • TEN 2
  • Target Price
  • TYRA $30.50
  • TEN $31.00
  • AVG Volume (30 Days)
  • TYRA 353.6K
  • TEN 417.3K
  • Earning Date
  • TYRA 05-08-2025
  • TEN 05-15-2025
  • Dividend Yield
  • TYRA N/A
  • TEN 9.25%
  • EPS Growth
  • TYRA N/A
  • TEN N/A
  • EPS
  • TYRA N/A
  • TEN 5.03
  • Revenue
  • TYRA N/A
  • TEN $804,061,000.00
  • Revenue This Year
  • TYRA N/A
  • TEN N/A
  • Revenue Next Year
  • TYRA N/A
  • TEN $11.19
  • P/E Ratio
  • TYRA N/A
  • TEN $3.23
  • Revenue Growth
  • TYRA N/A
  • TEN N/A
  • 52 Week Low
  • TYRA $6.42
  • TEN $13.40
  • 52 Week High
  • TYRA $29.60
  • TEN $31.48
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 45.95
  • TEN 51.49
  • Support Level
  • TYRA $8.23
  • TEN $15.13
  • Resistance Level
  • TYRA $8.80
  • TEN $16.01
  • Average True Range (ATR)
  • TYRA 0.70
  • TEN 0.93
  • MACD
  • TYRA 0.19
  • TEN 0.06
  • Stochastic Oscillator
  • TYRA 75.30
  • TEN 71.03

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About TEN TSAKOS ENERGY NAVIGATION

Tsakos Energy Navigation Ltd is a seaborne transportation service provider for crude oil and petroleum products. The company's carriers cater to national and international independent oil companies and refiners. It generates revenue through charter contracts with its clients, which include time, bareboat, and voyage charters, contracts of affreightment, and pool arrangements.

Share on Social Networks: